Cita APA

Kaira, K., Mouri, A., Kato, S., Yoshimura, K., Kagamu, H., & Kobayashi, K. (2020). A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A (trial in progress). BMC Cancer.

Chicago Style Citation

Kaira, Kyoichi, Atsuto Mouri, Shingo Kato, Kenichi Yoshimura, Hiroshi Kagamu, i Kunihiko Kobayashi. "A Phase II Study of Daily Carboplatin Plus Irradiation Followed By Durvalumab for Stage III Non-small Cell Lung Cancer Patients With PS 2 Up to 74 years Old and Patients With PS 0 or 1 From 75 years: NEJ039A (trial in Progress)." BMC Cancer 2020.

Cita MLA

Kaira, Kyoichi, et al. "A Phase II Study of Daily Carboplatin Plus Irradiation Followed By Durvalumab for Stage III Non-small Cell Lung Cancer Patients With PS 2 Up to 74 years Old and Patients With PS 0 or 1 From 75 years: NEJ039A (trial in Progress)." BMC Cancer 2020.